EUVIMEDEUVIMED entdecken
Crossref

Formulation and characterization of sevelamer carbonate immediate release tablets

{"name":"Vadamala Prudhvi Raj","email":"prudhvirajpharma9@gmail.com","affiliat, {"name":"L G Chaithra","email":"prudhvirajpharma9@gmail.com","affiliati, {"name":"P Mounika","email":"prudhvirajpharma9@gmail.com","affiliation", {"name":"M Naga Gouthami","email":"prudhvirajpharma9@gmail.com","affili, {"name":"C Swapna","email":"prudhvirajpharma9@gmail.com","affiliation":, {"name":"D Vandana","email":"prudhvirajpharma9@gmail.com","affiliation", {"name":"Y Jagadeesh","email":"prudhvirajpharma9@gmail.com","affiliatio, {"name":"M Niranjan Babu","email":"prudhvirajpharma9@gmail.com","affili

International Journal of Experimental and Biomedical Research · 02.04.2026 · 5 (2) · 1-9

DOI: 10.26452/ijebr.v5i2.552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Experimental and Biomedical Research, online erschienen am 02.04.2026. Verfasst von {"name":"Vadamala Prudhvi Raj","email":"prudhvirajpharma9@gmail.com","affiliat und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to formulate and evaluate a pharmaceutical study on formulating and characterising immediate - release tablets of Sevelamer carbonate, a non - absorbable phosphate binder used to treat hyperphosphatemia in chronic kidney disease patient s.Six formulations (F1 - F6) were developed using wet granulation with varying super disintegrants like cross - povidone and croscarmellose sodium, alongside excipients such as microcrystalline cellulose, magnesium stearate, and talc, followed by comprehensive pre - formulation, compression, and quality control evaluations, including FTIR compatibility, flow properties, weight variation, hardness, friability, disintegration, dissolution, and stability testing. Key findings highlight good powder flow (e.g., bulk d ensity 0.714 g/ml, Hausner's ratio 1.16), tablet quality within USP limits (friability 0.79%, disintegration ~2.18 min), and optimal drug release up to 82.56% at 90 minutes for F3, confirming suitability for rapid phosphate binding without drug - excipient i nteractions or stability issues over tested periods.

Zitieren

APA

Raj","email":"prudhvirajpharma9@gmail.com","affiliat, N. P., Chaithra","email":"prudhvirajpharma9@gmail.com","affiliati, N. G., Mounika","email":"prudhvirajpharma9@gmail.com","affiliation", N., Gouthami","email":"prudhvirajpharma9@gmail.com","affili, N. N., Swapna","email":"prudhvirajpharma9@gmail.com","affiliation":, N., Vandana","email":"prudhvirajpharma9@gmail.com","affiliation", N., Jagadeesh","email":"prudhvirajpharma9@gmail.com","affiliatio, N., & Babu","email":"prudhvirajpharma9@gmail.com","affili, N. N. (2026). Formulation and characterization of sevelamer carbonate immediate release tablets. International Journal of Experimental and Biomedical Research, 5(2), 1-9. https://doi.org/10.26452/ijebr.v5i2.552

Vancouver

Raj","email":"prudhvirajpharma9@gmail.com","affiliat NP, Chaithra","email":"prudhvirajpharma9@gmail.com","affiliati NG, Mounika","email":"prudhvirajpharma9@gmail.com","affiliation" N, Gouthami","email":"prudhvirajpharma9@gmail.com","affili NN, Swapna","email":"prudhvirajpharma9@gmail.com","affiliation": N, Vandana","email":"prudhvirajpharma9@gmail.com","affiliation" N, et al. Formulation and characterization of sevelamer carbonate immediate release tablets. International Journal of Experimental and Biomedical Research. 2026;5(2):1-9. doi:10.26452/ijebr.v5i2.552

BibTeX
@article{Rajemailprudhvirajpharmagmailcomaffiliat2026,
  author = {Raj","email":"prudhvirajpharma9@gmail.com","affiliat, "name":"Vadamala Prudhvi and Chaithra","email":"prudhvirajpharma9@gmail.com","affiliati, "name":"L G and Mounika","email":"prudhvirajpharma9@gmail.com","affiliation", "name":"P and Gouthami","email":"prudhvirajpharma9@gmail.com","affili, "name":"M Naga and Swapna","email":"prudhvirajpharma9@gmail.com","affiliation":, "name":"C and Vandana","email":"prudhvirajpharma9@gmail.com","affiliation", "name":"D and Jagadeesh","email":"prudhvirajpharma9@gmail.com","affiliatio, "name":"Y and Babu","email":"prudhvirajpharma9@gmail.com","affili, "name":"M Niranjan},
  title = {Formulation and characterization of sevelamer carbonate immediate release tablets},
  journal = {International Journal of Experimental and Biomedical Research},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {1--9},
  doi = {10.26452/ijebr.v5i2.552}
}
Kostenlos starten →